(dtpa-phe(1))-octreotide and Myasthenia-Gravis

(dtpa-phe(1))-octreotide has been researched along with Myasthenia-Gravis* in 1 studies

Other Studies

1 other study(ies) available for (dtpa-phe(1))-octreotide and Myasthenia-Gravis

Article	Year
Somatostatin receptor scintigraphy in thymoma imaging method and clinical application. Pathology, research and practice, 1999, Volume: 195, Issue:8 Somatostatin receptor scintigraphy with 111In-[DTPA-D-Phe1]-octreotide has the potential for visualizing primary and recurrent thymomas in patients with myasthenia gravis, whereas thymic hyperplasias fail to accumulate somatostatin analog peptides. We demonstrate somatostatin receptor imaging findings in a patient with a mixed encapsulated thymoma which exhibited intense 111In-[DTPA-D-Phe1]-octreotide uptake in early and late scans. In another patient with a history of malignant thymoma 111In-[DTPA-D-Phe1]-octreotide accumulation was clearly seen in a mass suspected to be a recurrence. This paper describes the imaging protocol including Single Photon Emission Computed Tomography (SPECT) and discusses the clinical applications of this feasible functional imaging method in patients with thymomas. Topics: Female; Humans; Male; Middle Aged; Myasthenia Gravis; Octreotide; Pentetic Acid; Radiopharmaceuticals; Receptors, Somatostatin; Thymoma; Thymus Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	1999

Article

Year

Somatostatin receptor scintigraphy in thymoma imaging method and clinical application.

Pathology, research and practice, 1999, Volume: 195, Issue:8

Somatostatin receptor scintigraphy with 111In-[DTPA-D-Phe1]-octreotide has the potential for visualizing primary and recurrent thymomas in patients with myasthenia gravis, whereas thymic hyperplasias fail to accumulate somatostatin analog peptides. We demonstrate somatostatin receptor imaging findings in a patient with a mixed encapsulated thymoma which exhibited intense 111In-[DTPA-D-Phe1]-octreotide uptake in early and late scans. In another patient with a history of malignant thymoma 111In-[DTPA-D-Phe1]-octreotide accumulation was clearly seen in a mass suspected to be a recurrence. This paper describes the imaging protocol including Single Photon Emission Computed Tomography (SPECT) and discusses the clinical applications of this feasible functional imaging method in patients with thymomas.

Topics: Female; Humans; Male; Middle Aged; Myasthenia Gravis; Octreotide; Pentetic Acid; Radiopharmaceuticals; Receptors, Somatostatin; Thymoma; Thymus Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

1999